Chemical Biology & Drug Design

Scope & Guideline

Elevating the standards of biochemistry and drug development.

Introduction

Welcome to your portal for understanding Chemical Biology & Drug Design, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1747-0277
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCHEM BIOL DRUG DES / Chem. Biol. Drug Des.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The journal "Chemical Biology & Drug Design" focuses on the integration of chemical biology and medicinal chemistry to develop new therapeutic agents and understand their mechanisms of action. It aims to bridge the gap between chemistry and biology, emphasizing innovative drug design, synthesis, and evaluation methodologies.
  1. Medicinal Chemistry:
    The journal emphasizes the design and synthesis of novel chemical compounds with potential therapeutic applications, particularly in cancer, infectious diseases, and chronic conditions.
  2. Chemical Biology:
    Research that explores the interactions between biological systems and chemical entities, including the mechanisms behind drug action and biological pathways.
  3. Drug Development and Design:
    The journal features works related to the development of new drugs, including formulation strategies, delivery systems, and efficacy evaluations.
  4. Network Pharmacology:
    A focus on understanding the multi-target interactions of drugs within biological networks, which is essential for elucidating complex disease mechanisms.
  5. In Silico Studies:
    Emphasizes computational approaches in drug discovery, including molecular docking, QSAR modeling, and machine learning applications to predict biological activity.
  6. Natural Products Chemistry:
    Explores the therapeutic potential of natural compounds and their derivatives, focusing on their isolation, structural elucidation, and biological activities.
Recent publications in "Chemical Biology & Drug Design" indicate a shift towards innovative and interdisciplinary approaches in drug discovery and development. The following themes have emerged as significant focuses of research.
  1. Targeted Cancer Therapies:
    An increasing number of studies are focusing on targeted therapies that leverage specific molecular pathways in cancer treatment, reflecting the growing understanding of tumor biology.
  2. Combination Therapies:
    Research is trending towards exploring the efficacy of combination therapies that utilize multiple agents to enhance therapeutic outcomes and overcome resistance mechanisms.
  3. Biologics and Biopharmaceuticals:
    The emergence of biologics as therapeutic agents, including monoclonal antibodies and protein-based drugs, is gaining traction, emphasizing the need for advanced drug design techniques.
  4. Machine Learning and AI in Drug Discovery:
    The integration of machine learning and artificial intelligence into drug discovery processes is becoming increasingly prominent, aiding in predictive modeling and optimization of drug candidates.
  5. Natural Product Derivatives:
    There is a growing interest in the modification of natural products to enhance their pharmacological properties, with a focus on their potential as leads for new drug development.
  6. Nanotechnology in Drug Delivery:
    Research is increasingly focusing on the application of nanotechnology for drug delivery systems, enhancing the bioavailability and targeting of therapeutic agents.

Declining or Waning

While the journal maintains a robust focus on various emerging themes, certain areas have seen a decline in prominence over recent years. This may reflect shifts in research priorities or advancements in specific methodologies.
  1. Traditional Antimicrobial Agents:
    Research focusing on conventional antibiotics and their mechanisms has become less prevalent as the field moves towards exploring novel and multi-targeted therapeutic strategies.
  2. Single-Target Drug Design:
    There is a noticeable decrease in studies centered around single-target drugs, as the complexity of diseases has led to a shift towards multi-target approaches and combination therapies.
  3. In vitro Only Studies:
    Research that solely relies on in vitro models without in vivo validation has waned, as the scientific community increasingly emphasizes the importance of comprehensive in vivo studies to support findings.
  4. Synthetic Methods with Limited Applicability:
    The use of traditional synthetic methods without innovative adaptations or applications in drug design has seen a decline, as researchers seek more versatile and efficient synthetic strategies.

Similar Journals

ACS Bio & Med Chem Au

Driving innovation in therapeutic strategies through rigorous research.
Publisher: AMER CHEMICAL SOCISSN: Frequency: 6 issues/year

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

TURKISH JOURNAL OF CHEMISTRY

Innovative Insights for a Dynamic Discipline
Publisher: Tubitak Scientific & Technological Research Council TurkeyISSN: 1300-0527Frequency: 6 issues/year

TURKISH JOURNAL OF CHEMISTRY, published by the Tubitak Scientific & Technological Research Council Turkey, serves as a significant platform for the dissemination of research in the diverse field of chemistry. Since its inception in 1996, this peer-reviewed journal has made substantial contributions to the body of knowledge within the field, currently holding a respectable Q3 ranking in the category of Chemistry (miscellaneous) as of 2023. Researchers and professionals alike rely on this journal for its wide-ranging discussions, innovative methodologies, and noteworthy findings pertinent to both fundamental and applied chemistry. With an ISSN of 1300-0527 and a commitment to promoting scientific progress, the journal is accessible to a global audience and encourages the open sharing of insights that drive advancements in chemistry. The extended timeframe of convergence until 2024 highlights the journal's dedication to fostering ongoing research and collaboration within the scientific community. As a valuable resource for researchers, professionals, and students, the Turkish Journal of Chemistry aims to inspire new discoveries and facilitate knowledge transfer in a dynamic and evolving discipline.

Medicinal Chemistry

Exploring the intricate world of medicinal chemistry.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4064Frequency: 8 issues/year

Medicinal Chemistry is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of drug discovery and development. Established in 2005 with a converged publication timeframe extending to 2024, this journal serves as a vital resource for researchers and professionals interested in the intricate processes of medicinal chemistry, pharmacology, and toxicology. With an ISSN of 1573-4064 and an E-ISSN of 1875-6638, it has established a notable presence in the academic community, currently positioned in Q3 of Drug Discovery category according to the 2023 quartiles. The journal's ranking in Scopus places it at 90 out of 157 in its field, showcasing its impact and relevance, with a percentile standing of 42. Although the journal is not open access, it continues to provide insightful articles and research findings that contribute significantly to the understanding and innovation in medicinal chemistry. Based in the United Arab Emirates, Medicinal Chemistry is committed to disseminating high-quality research that shapes the future of drug formulation and therapeutic advancement.

MOLECULAR DIVERSITY

Connecting Chemistry, Biology, and Pharmacology for a Better Tomorrow
Publisher: SPRINGERISSN: 1381-1991Frequency: 4 issues/year

MOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.

Letters in Drug Design & Discovery

Empowering Discovery through Collaborative Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1570-1808Frequency: 12 issues/year

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY

Bridging Theory and Practice in Bioorganic Science
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1068-1620Frequency: 7 issues/year

Russian Journal of Bioorganic Chemistry (ISSN: 1068-1620, E-ISSN: 1608-330X), published by MAIK Nauka/Interperiodica/Springer, serves as a vital resource for researchers and professionals in the fields of bioorganic chemistry, biochemistry, and organic chemistry. With a focus on the integration of organic chemistry principles with biological processes, this journal aims to disseminate significant findings and advancements from both theoretical and practical perspectives. Although currently not open access, the journal retains a dedication to high-quality, peer-reviewed content, contributing to its reputation within the academic community. The 2023 Scopus rankings position it within the Q4 category for both biochemistry and organic chemistry, indicating its critical niche within these disciplines amid a competitive landscape. Since its inception in 1996, the journal has continued to evolve, providing enriching insights and fostering collaborations among scholars and practitioners alike, with publication converging up to the year 2024. By exploring complex biomolecular interactions and the synthesis of biologically relevant compounds, the Russian Journal of Bioorganic Chemistry remains a significant platform for advancing knowledge and innovation in the life sciences.

Journal of Natural Medicines

Pioneering Discoveries in Organic Chemistry and Herbal Science
Publisher: SPRINGER JAPAN KKISSN: 1340-3443Frequency: 4 issues/year

Journal of Natural Medicines, published by SPRINGER JAPAN KK, is a leading academic journal that plays a pivotal role in the advancement of research in the fields of Complementary and Alternative Medicine, Drug Discovery, Molecular Medicine, Organic Chemistry, and Pharmaceutical Science. Established in 1994 and set to continue until 2024, this journal serves as a vital conduit for the dissemination of groundbreaking research and innovative ideas that bridge traditional medicinal knowledge and modern scientific inquiry. With its impressive ranking in Scopus—ranking #12 out of 105 in Complementary and Alternative Medicine and holding a Q1 category quartile for 2023—it stands as a reputable source for high-quality, peer-reviewed articles. The journal's commitment to excellence is further underscored by its inclusion in the Springer network, providing researchers, professionals, and students with valuable insights and the latest developments in natural medicines. Although this journal operates under a subscription model, its profound impact on these interdisciplinary fields makes it an essential resource for anyone engaged in the study or practice of natural medicinal therapies.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Illuminating Paths in Analytical Chemistry and Beyond
Publisher: TAYLOR & FRANCIS LTDISSN: 1028-6020Frequency: 12 issues/year

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.

MONATSHEFTE FUR CHEMIE

Advancing Knowledge in the Heart of Chemical Sciences
Publisher: SPRINGER WIENISSN: 0026-9247Frequency: 12 issues/year

MONATSHEFTE FUR CHEMIE, an esteemed journal published by Springer Wien, has been a significant contributor to the field of chemistry since its inception in the late 19th century. With a rich history spanning from 1880 to the present, this journal provides a platform for innovative research and comprehensive reviews in various areas of general chemistry. Although it currently holds a Q3 ranking in the miscellaneous category of chemistry, its commitment to maintaining high academic standards is reflected in its continued relevance and citation impact, as evidenced by its Scopus ranking. Researchers, professionals, and students engaged in chemical sciences will find this journal a valuable resource for advancing their knowledge and contributing to ongoing discussions in the field. For those looking to stay updated on the latest developments in chemistry while engaging with a storied publication, MONATSHEFTE FUR CHEMIE is a pivotal source of insightful content.

Open Chemistry

Catalyzing Progress in Chemistry and Materials Science
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2391-5420Frequency: 1 issue/year

Open Chemistry, published by DE GRUYTER POLAND SP Z O O, is a distinguished peer-reviewed journal that has been serving the global chemistry community since its inception. With an ISSN of 2391-5420 and an E-ISSN also of 2391-5420, this open-access journal has been accessible to researchers and practitioners alike since 2015, ensuring a wide dissemination of high-quality research findings. Located in Germany, specifically at BOGUMILA ZUGA 32A STR, 01-811 WARSAW, MAZOVIA, POLAND, Open Chemistry aims to publish innovative research across various chemical disciplines, with special attention to miscellaneous chemistry and materials chemistry. It is currently ranked in the Q3 category for both fields as of 2023, reflecting its solid standing within the academic community, with specific ranks of 187/408 in General Chemistry and 153/317 in Materials Chemistry, corresponding to respective percentiles of 54 and 51. Open Chemistry not only enhances the accessibility of cutting-edge research but also serves as a vital resource for students, professionals, and scholars seeking to advance their knowledge in the rapidly evolving landscape of chemical sciences.